Racial differences in venous thromboembolism
Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome
Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis
Comparison of two prognostic models for acute pulmonary embolism: clinical vs. right ventricular dysfunction-guided approach
Treatment of upper-extremity deep vein thrombosis
Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity
Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss
Surgery and inhibitor development in hemophilia A: a systematic review
Activation of hemostasis in brain dead organ donors: an observational study
No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy
Mutations in disguise
Point mutations regarded as missense mutations cause splicing defects in the factor XI gene
Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome
Validation of an automated latex particle–enhanced immunoturbidimetric von Willebrand factor activity assay
The factor VIII inhibitor assays can be standardized: results of a workshop
Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors
Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram-negative sepsis (melioidosis)
A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions
Streptococcus sanguinis-induced cytokine release from platelets
Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel
Involvement of circulating platelets on the hyperalgesic response evoked by carrageenan and Bothrops jararaca snake venom
The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies
Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis
Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling
An international collaborative study to establish the WHO 1st international standards for C1-inhibitor, plasma and concentrate
Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316)
Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrel
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin
Effect of 5-HT2A receptor antagonists on human platelet activation in blood exposed to physiologic stimuli and atherosclerotic plaque
The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism
ISTH/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories?
Association of the C3435T polymorphism of the MDR1 gene and therapeutic doses of warfarin in thrombophilic patients
A proposed ternary complex model of prothrombinase with prothrombin: protein–protein docking and molecular dynamics simulations
More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required
Low-molecular-weight-heparin and pregnancy, when the dose does it: a nephrologist's opinion: a rebuttal
Low-molecular-weight-heparin and pregnancy, when the dose does it: a nephrologist's opinion: reply to a rebuttal